Jackie Kennedy‐Wilde

Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models

Kevin Nishimoto, Taylor Barca, Aruna Azameera et al. · Clinical & Translational Immunology · 2022 · 113 citations · Full text

Life Sciences, Immunology, Oncology +15

A phase 1 study of ADI-001: Anti-CD20 CAR-engineered allogeneic gamma delta (γδ) T cells in adults with B-cell malignancies.

Sattva S. Neelapu, Mehdi Hamadani, David B. Miklos et al. · Journal of Clinical Oncology · 2022 · 45 citations

Life Sciences, Immunology, Cancer Immunology +13

A Phase 1 Study of ADI-001: Anti-CD20 CAR-Engineered Allogeneic Gamma Delta1 (γδ) T Cells in Adults with B-Cell Malignancies

Sattva S. Neelapu, Don A. Stevens, Mehdi Hamadani et al. · Blood · 2022 · 31 citations

Life Sciences, Immunology, Oncology +16

Expansion, Persistence and Pharmacodynamic Profile of ADI-001, a First-in-Class Allogeneic CD20-Targeted CAR Gamma Delta T Cell Therapy, in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Monica Moreno, Jackie Kennedy‐Wilde, Andrew D Wrong et al. · Blood · 2023 · 11 citations

Medicine, Pharmacology, Cell Therapy +13